Oğuz YÜCEL, Tayyibe SALER, Meriş Esra BOZKURT

An investigation into thyroid function tests in pregnant women and the relationship between thyroid autoantibodies and preeclampsia

Aim: Preeclampsia and eclampsia which can be seen during the last trimester of pregnancy prove to be signifiant pregnancycomplications whose physiopathology still remains unclear. Available data demonstrate that disorders of the thyroid hormone maypossibly alter the progress of pregnancy. The aim of this study was to investigate the relationship between thyroid antibodies andpreeclampsia development.Materials and Methods: This retrospective study is a total of 216 cases were included in the study out of which 72 were pregnantwomen with preeclampsia who had been followed-up at University of Medical Sciences, Adana City Hospital, Obstetrics andGynecology Clinic, 72 were healthy pregnant women followed-up at the same clinic, and 72 healthy non-pregnant women but hadpresented to the internal medicine clinic for various reasons. Statistical analyses of the comparisons of the thyroid tests and thyroidautoantibodies among the all three groups were conducted as well.Results: 45 of the patients with preeclampsia had mild preeclampsia, while 27 had severe preeclampsia. While no signifiantdifference was found among pregnant women with preeclampsia, healthy pregnant women, and the control groups with regardsto the Thyroid Stimulating Hormone (TSH) values as revealed by intergroup and intragroup comparisons for multiple groups,the free triiyodotironin(fT3) and free tetraiyodotironin (fT4) values were found to be signifiantly lower in the preeclampsia andhealthy pregnant groups at an advanced level than the control group statistically (p 0.005).Conclusion: The results of our study revealed that the alterations seen in thyroid hormones might pose a risk for preeclampsiadevelopment but autoantibodies were not suffiient enough to bring about preeclampsia development

PDF

___

1. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081.
2. Kurioka H, Takahashi K, Miyazaki K. Maternal Thyroid Function during Pregnancy and Puerperal Period. Endocrine Journal 2005;52:587-91.
3. Stagnaro-Green A, Roman SH, Cobin RH, et.al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies.JAMA. 1990;264:1422-5.
4. Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. Clin Endocrinol Metab 1991;73:421-7.
5. Yenigul NN, Asicioglu O, Ayhan I. Perinatal outcomes of adolescent pregnancy: A singlecenter experience. Ann Med Res 2019;26:676-80.
6. Sağol S, Özkınay E. Preeklampsi etyopatogenezinde lipid peroksidasyonu. Türkiye Klinikleri Jinekolojik Obstetrik Dergisi 2000;10:7-15.
7. Steegers EA, Von Dadelszen P, Duvekot JJ, et al. Lancet 2010;376:631-44.
8. Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health 2011;11: S8-10.1186/1471-2458-11-S3-S8.
9. Enaam TE, Ishag A, Ammar A, et al. Thyroid function/ antibodies in Sudanese patients with preeclampsia Front. Endocrinol 2015:11.
10. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006.
11. Mecacci F, Parretti E, Cioni R, et al. Thyroid autoimmunity and its association with non-organspecifi antibodies and subclinical. J Reprod Immunol 2000.
12. Fisher DA, Polk DH, Wu SY. Fetal tyhroid metabolism: a pluralistic system. Thyroid 1994;4:367-71.
13. Lao TT, Chin RK, Swaminathan R. Tyhroid fuction in preeclampsia. Br J Obstet Gynaecol 1988;95:880-3.
14. Qublan HS, Al-Kaisi IJ, Hindawi IM, et al. Severe preeclampsia and maternal thyroid function. J Obstet Gynecol May 2003;3:244-6.
15. Kumar A, Ghosh BK, Murthy NS. Maternal thyroid hormonal status in preeclampsia Indian Journal of Medical Sciences, February, 2005;59:57-63.
16. Lao TT, Chin RK, Swaminathan R, et al. Maternal thyroid hormones and outcome of pe-eclamptic pregnancies. Br J Obstet Gynaecol 1990;97:71-4.
17. Volvodic LJ, Sulovic V, Pervulov M. The effect of preeclampsia on thyroid gland function. Srpski Arhiv za Celokupno Lekarstvo 1993;121:4-7.
18. Zhou J, Li W, Du J, et al. Correlation between thyroid hormones and renal function in severe pre-eclampsia patients with hypothyroidism. Zhonghua Fu Chan Ke Za Zhi 2014;49:811-5.
19. Basebug A. Correlation Between Maternal Thyroid FunctionTests and Endothelin in PreeclampsiaEclampsia Obstetrics & Gynecology, October 1999; 94:4.
20. Levine RJ, Vatten LJ, Horowitz GL, et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ. 2009;339:4336.
21. Raoof Z, Jalilian A, Shabani, et al. Comparison of thyroid hormone levels between normal and preeclamptic pregnancies. Med J Islam Repub Iran 2014;12:28:1.
22. Suziki S, Yoneyama Y, Sawa R, et al. Relation betwen serum uric acid and plasma adenosine levels in women with preeclampsia. Gynecol Obstet Invest 2001;51:169-72.
23. D’anna R, Baviera G, Scilipoti A, et al. The clinical utility of serom uric acid measurements in preeclampsia and transient hypertension in pregnancy. Panminerva Med 2004;42:101-3.
24. Makuyana D, Mahomed K, Shukusho FD, et al. Liver and kidney function tests in normal and preeclamptic gestation--a comparison with nongestational reference values. Cent Afr J Med 2002;48:55-9.
25. Martin JN Jr, Blake PG, Lowry SL, et al. Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: how rapid is postpartum recovery? Obstet Gynecol. 1990;76:737-41.
26. Vagdatli E, Gounari E, Lazaridou E, et al. Platelet distribution width: a simple, practical and specif c marker of activation of coagulation. Hippokratia 2010; 14:28-32.
27. Holthe MR, Staff AC, Berge LN, et al. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 2004;190:1128-34.
28. Edelstam G, Lowbeer C, Kral G, et al. New reference values for routine blood samples and human neutrophilic lipocalin during third-trimester pregnancy. Scand J Clin Lab Invest 2001;61:583-92.
29. Akingbola TS, Adewole IF, Adesina OA, et al. Haematological prof le of healthy pregnant women in Ibadan, south-western Nigeria. J Obstet Gynaecol 2006;26:763-9.
30. Dundar O, Yoruk P, Tutuncu L, et al. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of preeclampsia. Prenat Diagn 2008;28:1052-6.
31. Järemo P, Lindahl TL, Lennmarken C, et al. The use of platelet density and volume measurements to estimate the severity of pre-eclampsia. Eur J Clin Invest 2000;30:1113-8.
32. Neiger R, Contag SA, Coustan DR. Preeclampsia effect on platelet count. Am J Perinatol 1992;9:378-80.
33. Taşın C, Yıldız Y, Ünlü BS, et al. Hafi ve Şiddetli Preeklampsi Olgularında Maternal ve Perinatal Bulguların Değerlendirilmesi, Kocatepe Tıp Dergisi Kocatepe Medical Journal 2014;15:7-12